RETAGLIX
Retatrutide 10mg 20mg 40mg
Retatrutide is a triple GIP, GLP-1, and glucagon receptor agonist designed to support weight management, enhance fat loss, and promote overall wellness.
Triple GIP/GLP-1/Glucagon Receptor Agonist
Targets GIP, GLP-1, and glucagon receptors to support advanced metabolic health and appetite regulation.
Supports Weight Management
Clinically shown to support significant weight loss through appetite control and metabolic enhancement.
Improves Metabolic Health
Supports blood sugar control, lipid metabolism, and overall cardiovascular health.
Pharmaceutical Grade
Produced in FDA-registered facilities with the highest quality standards.
Product Description
Retatrutide is an advanced triple GIP, GLP-1, and glucagon receptor agonist that works synergistically to regulate appetite, enhance energy expenditure, improve glycemic control, and support significant weight loss.
Each vial contains high-purity Retatrutide, lyophilized for stability and efficacy.
For Subcutaneous Use Only.
Key Benefits
-
Promotes significant weight loss
-
Supports appetite control and reduces food cravings
-
Helps maintain healthy blood sugar levels
-
Enhances metabolic function and insulin sensitivity
-
Increases energy expenditure and fat metabolism
-
Advanced triple-action GIP, GLP-1, and glucagon receptor agonist
Product Details
Active Ingredient: Retatrutide
Concentration : 10mg 20mg 40mg per vial.
Form: Lyophilized powder
Use: Subcutanous injection
Storage: After reconstitution, refrigerate.
Manufactured in : USA